Angel investors
Useful for early validation, specialist introductions, and the first hires before institutional capital fits.
Best for: proof of demand
UK funding desk
Fuel for innovation
Great ideas need fuel. Find the funding, support, and practical decisions that turn research into thriving businesses.
Peak Forge Ltd. follows venture capital, public grants, university spinouts, and the founders building companies across the UK.
Explore funding guidesThe funding desk
Where money meets ideas
The right capital depends on timing, evidence, and the job the money must do. Here is how the main routes differ.
Venture capital
VC suits businesses with a clear route to a large market and a plan for measured, rapid hiring.
Best for: repeatable growth
Public grants
Innovate UK and Scottish Enterprise can support technical work where commercial risk remains high.
Best for: research-heavy work
Crowdfunding
A strong campaign tests customer interest in public and creates a wider group of early supporters.
Best for: visible products
£9.7bn
UK technology investment tracked in our latest sector review.
4 routes
Capital paths founders can compare before the next board meeting.
12 months
A useful planning horizon for runway, milestones, and the next raise.
Founder profiles
Emerging ventures to watch
Three regions. Three different routes to traction. We look at the evidence behind each company’s next decision.
London · climate software
Selling certainty to busy operators
The team moved from pilot contracts to annual subscriptions after narrowing its product to one costly reporting task.
£2.4mraised to date
18 monthsrunway planned
"A narrow promise made our sales calls much sharper."
Manchester · industrial AI
Scaling after the first factory
A university pilot became a paid deployment when the founders measured downtime avoided rather than model accuracy alone.
7 sitesin operation
31%less downtime
"Factories buy a result they can see on a shift report."
Edinburgh · health technology
Building trust before scale
The company paired clinical validation with a commercial lead, giving investors a clearer view of adoption and regulation.
£1.1mseed round
3 trustsin pilot
"Clinical proof gives the whole team a steadier pace."
Research to market
The university spinout playbook
Commercialisation works best when ownership, evidence, and roles are clear before the first large round.
01 · Protect the work
Set the IP position early
Record inventorship, review existing agreements, and decide what belongs in a patent, licence, or trade secret. Investors need a clean chain of ownership.
02 · Licence with purpose
Match rights to the route to market
A licence should reflect territory, field of use, milestones, and the resources needed to develop the technology beyond the lab.
03 · Build the team
Pair deep research with market fluency
The founding group needs someone who can speak to customers, manage delivery, and translate technical progress into commercial milestones.
04 · Fund the proof
Raise around the next decision
The first round should pay for a defined technical or customer milestone. A Scottish life sciences spinout we reviewed used that discipline to move from lab data to three hospital pilots.
Read the full spinout case study
See how a Scottish research team handled licensing, hiring, and its first institutional round.
Regional strengths
UK innovation hotspots
Capital and specialist talent cluster in different places. Founders should know what each region does well before choosing where to grow.
London
Fintech, climate software, global capital.
Cambridge
Life sciences, engineering, deep research.
Oxford
Medicine, materials, university spinouts.
Manchester
Industrial technology, media, digital health.
Glasgow
Space systems, advanced manufacturing, energy.
Edinburgh
Artificial intelligence, finance, health technology.
Belfast
Cyber security, aerospace, connected systems.
Regional support matters. Scottish Enterprise, local growth hubs, university enterprise offices, and specialist accelerators each bring a different kind of help.
Share a local storyInsights from the front line
"The first fundraising story should be about the next proof point. Investors can follow a clear test, a clear owner, and a clear date."
Michella Toong
Founder adviser, UK research commercialisation
Her advice is direct: keep the technical plan ambitious, then make the commercial milestone small enough to measure. That discipline protects runway and gives a new team useful evidence before it hires ahead of demand.
The latest briefing
Latest funding news
Short reads on capital, company building, and research commercialisation across the UK.
Venture capital · 6 min read
What investors ask after the first pilot
A practical look at retention, procurement, pricing evidence, and the numbers that shape a seed round.
Read briefingSpinouts · 8 min read
The term sheet questions researchers miss
Equity, licensing rights, founder roles, and the clauses that affect a company long after incorporation.
Read briefingRegional growth · 5 min read
Why local networks change a scaling plan
The specialist advisers, first customers, and technical hires that can make a regional base commercially useful.
Read briefingGet the funding briefing
A concise email on UK innovation funding, startup scaling, and spinout news.